Showing results (21-30 of 38) with videos related to
Sort By:
Pageof 4
Nephrologie|February 24, 2001
[Renal osteodystrophy (3); its treatment in dialysis patients]S Ghitu, R Oprisiu, L Benamar, et al.Nephrologie|November 9, 2000
[Renal osteodystrophy (1): invasive and non-invasive diagnosis of its pathologic varieties]R Oprisiu, C Hottelart, S Ghitsu, et al.Presse Medicale (Paris, France : 1983)|February 22, 2000
[Renal and hypertensive complications of extracorporeal lithotripsy]P Bataille, A Pruna, G Cardon, et al.Canadian Journal of Physiology and Pharmacology|October 1, 1991
Atrial natriuretic factor in pregnancy and pregnancy-induced hypertensionA Fournier, I Gregoire, N el Esper, et al.Urologia Internationalis|November 24, 1999
Renal and hypertensive complications of extracorporeal shock wave lithotripsy: who is at risk?P Bataille, G Cardon, M Bouzernidj, et al.Kidney International. Supplement|June 1, 1993
Improvement of severe secondary hyperparathyroidism in dialysis patients by intravenous 1 alpha(OH) vitamin D3, oral CaCO3 and low dialysate calciumP Moriniere, N el Esper, B Viron, et al.BMJ (Clinical Research Ed.)|October 1, 1994
Randomised controlled trial of enalapril and beta blockers in non-diabetic chronic renal failureT Hannedouche, P Landais, B Goldfarb, et al.Nephron|January 1, 1995
1-alpha-Hydroxyvitamin D3 derivatives in the treatment of renal bone diseases: justification and optimal modalities of administrationA Fournier, P H Morinière, R Oprisiu, et al.Nephron|January 1, 1992
Prevention of hyperparathyroidism in patients on maintenance dialysis by intravenous 1-alpha-hydroxyvitamin D3 in association with Mg(OH)2 as sole phosphate binder. A randomized comparative study with the association CaCO3 +/- Mg(OH)2P Mornière, C Maurouard, B Boudailliez, et al.The American Journal of Cardiology|December 22, 1994
Pharmacokinetics of rilmenidine in patients with chronic renal insufficiency and in hemodialysis patientsM Aparicio, M Dratwa, N el Esper, et al.Pageof 4